Stanley M. Gloss
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stanley M. Gloss
Stanley M. Gloss was last confirmed as CFO at Pasithea Therapeutics Corp. (KTTA) in a filing dated May 13, 2022. The proxy statement of Pasithea Therapeutics Corp. reports total compensation of $60,000 for Stanley M. Gloss in fiscal 2022, including a base salary of $60,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-05-13
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Pasithea Therapeutics Corp. (KTTA) | Former Chief Financial Officer | $60,000 | $60,000 |
| 2021 | Pasithea Therapeutics Corp. (KTTA) | Former Chief Financial Officer | $67,500 | $412,165 |
| 2020 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.